Diagnosis and prognosis in acute myeloid leukemia - The art of distinction

New England Journal of Medicine

Volumn 358, Issue 18, 2008, Pages 1960-1962

  Löwenberg, Bob ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLT3 LIGAND;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER PATIENT; CHROMOSOME TRANSLOCATION; CLINICAL RESEARCH; CYTOGENETICS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; EDITORIAL; GENETIC RISK; GENOTYPE; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; LEUKEMIA RELAPSE; PRIORITY JOURNAL; PROGNOSIS;

EID: 42949104680     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0802379     Document Type: Editorial

References (11)

1. RF Schlenk K Dohner J Krauter Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 358 2008 1909 1918
2. G Marcucci MD Radmacher K Maharry MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 358 2008 1919 1928
3. JJ Cornelissen WLJ van Putten LF Verdonck Results of a HOVON-SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle aged adults: benefits for whom? Blood 109 2007 3658 3666
4. A Gratwohl J Hermans JM Goldman Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Lancet 352 1998 1087 1092
5. ML Sorror BM Sandmeier BE Storer Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia and myelodysplasia receiving allogeneic hematopoietic stem cell transplantation. J Clin Oncol 25 2007 4246 4254
6. R Garzon M Garofalo MP Martelli Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A 105 2008 3945 3950
7. R Garzon S Volinia CG Liu MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111 2008 3183 3189
8. Jongen-Lavrencic M, Sun SM, Dijkstra MK, Valk PJM, Lowenberg B. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood (in press).
9. M Heuser G Beutel J Krauter High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Blood 108 2006 3898 3905
10. C Erpelinck WLJ van Putten High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 101 2003 837 845
11. S Lugthart E Van Drunen Y Van Norden High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood 111 2008 4329 4337